OpenAI CEO Denies Plans for IPO: Here’s Why

Date:

OpenAI CEO, Sam Altman, has declared that the company has no current plans to go public. During a conference held in Abu Dhabi, Altman stated that he was not interested in the world of Wall Street and public markets. OpenAI has raised $10bn since its inception, with a valuation of nearly $30bn. Known for its artificial intelligence (AI) via content-generating ChatGPT, OpenAI started as a non-profit but later transformed into a “capped profit” hybrid. This allowed it to receive external investment while still enjoying the benefits of a non-profit organisation. Scientists involved with marketing and creating AI have warned about the threat it poses, particularly content-generating generative AI such as ChatGPT. Some have even suggested it poses an extinction-level risk, and regulation must be implemented. Altman previously commented that if it became difficult for OpenAI to comply with AI regulation laws, the company may leave the EU. However, on reflection, Altman announced that they did not threaten to leave Europe and are excited to operate there.

See also  New York Times Sues Microsoft and OpenAI for Copyright Infringement, US

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.